{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:31:38Z","timestamp":1793773898937,"version":"4.6.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100029005","name":"Arthur M. Blank Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.medj.2025.100879","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:40Z","timestamp":1761856240000},"page":"100879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Modulating the cold tumor microenvironment"],"prefix":"10.1016","volume":"6","author":[{"given":"Sujit S.","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimple","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekumar","family":"Balan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hakansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin Htwe","family":"Thin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Garcia-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd","family":"Al Shaarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Meseck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parita","family":"Ratnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monali","family":"Fatterpekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gonzalez-Gugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Wagaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Jambor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacie","family":"Schlussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pasat-karasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Dovey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akriti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Lundon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ante","family":"Peros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macy","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Knauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Rykunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Reva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Padanilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Galsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh K.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100879_bib1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification","volume":"27","author":"Shore","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.medj.2025.100879_bib2","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1200\/JCO.2022.40.16_suppl.5090","article-title":"Recurrence, metastasis, and survival after radical prostatectomy in the era of advanced treatments","volume":"40","author":"Stensland","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100879_bib3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2009.22.2265","article-title":"Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix","volume":"28","author":"Zelefsky","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100879_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage Therapy for Prostate Cancer: AUA\/ASTRO\/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J. Urol."},{"key":"10.1016\/j.medj.2025.100879_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41585-021-00514-9","article-title":"Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer","volume":"18","author":"Devos","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.medj.2025.100879_bib6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.trecan.2023.07.011","article-title":"Genitourinary cancer neoadjuvant therapies: current and future approaches","volume":"9","author":"Nair","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/iju.IJU_115_20","article-title":"Neoadjuvant Therapy in High-Risk Prostate Cancer","volume":"36","author":"Ashrafi","year":"2020","journal-title":"Indian J. Urol"},{"key":"10.1016\/j.medj.2025.100879_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1389450121666200621194409","article-title":"Neoadjuvant Strategies Before Radical Prostatectomy for High Risk Prostate Cancer in the Era of New Hormonal Agents","volume":"22","author":"Tafuri","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.medj.2025.100879_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fruro.2022.864646","article-title":"Neoadjuvant Systemic Therapy Prior to Radical Prostatectomy for Clinically Localized High-Risk Prostate Cancer","volume":"2","author":"Perera","year":"2022","journal-title":"Front. Urol."},{"key":"10.1016\/j.medj.2025.100879_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-022-01681-x","article-title":"Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery","volume":"28","author":"Marron","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100879_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ucl.2020.08.001","article-title":"Immunotherapy for Genitourinary Cancers: New Opportunities for Clinical Impact","volume":"47","author":"Nair","year":"2020","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.medj.2025.100879_bib12","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ucl.2020.10.005","article-title":"The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.medj.2025.100879_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.medj.2025.100879_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The Molecular Taxonomy of Primary Prostate Cancer","volume":"163","author":"Abeshouse","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.medj.2025.100879_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.medj.2025.100879_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40425-018-0479-7","article-title":"High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors","volume":"6","author":"Maleki Vareki","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1158\/2326-6066.CIR-14-0024","article-title":"Therapeutic in situ autovaccination agains solid cancer siwth intratumoral poly-ICLC: Case report, Hypothesis, and Clinical Trial","volume":"2","author":"Salazar","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.medj.2025.100879_bib18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1227\/00006123-199606000-00006","article-title":"Long-term treatmen of malignant gliomas with intramuscular poly-ICLC: an open pilot study","volume":"38","author":"Salazar","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.medj.2025.100879_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101414","article-title":"Poly-ICLC a multifunctional immune modulator for treating cancer","volume":"49","author":"Sultan","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.medj.2025.100879_bib20","doi-asserted-by":"crossref","first-page":"CT096","DOI":"10.1158\/1538-7445.AM2019-CT096","article-title":"Abstract CT096: Phase I study of in situ autologous vaccination for prostate cancer in a neo-adjuvant setting","volume":"79","author":"Nair","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib21","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S2666-1683(23)00044-7","article-title":"Phase I study of in-situ autologous vaccination for prostate cancer in a neo-adjuvant setting","volume":"48","author":"Tewari","year":"2023","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.medj.2025.100879_bib22","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1158\/1078-0432.CCR-17-1866","article-title":"Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial","volume":"24","author":"Kyi","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000655","article-title":"Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer","volume":"8","author":"Abdul Sater","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41591-023-02284-w","article-title":"Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial","volume":"29","author":"Shenderov","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100879_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju268","article-title":"Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer","volume":"106","author":"Fong","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.medj.2025.100879_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1486953","article-title":"Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer","volume":"8","author":"Hagihara","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.medj.2025.100879_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001157","article-title":"Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I\/II clinical trial","volume":"8","author":"Schuhmacher","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib28","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/annonc\/mdy423","article-title":"Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)","volume":"29","author":"Marabelle","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.medj.2025.100879_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/1078-0432.CCR-20-0473","article-title":"Intratumoral Immunotherapy: From Trial Design to Clinical Practice","volume":"27","author":"Champiat","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100879_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106646","article-title":"In situ vaccination followed by intramuscular poly-ICLC injections for the treatment of hepatocellular carcinoma in mouse models","volume":"188","author":"Weng","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.medj.2025.100879_bib32","doi-asserted-by":"crossref","first-page":"CT023","DOI":"10.1158\/1538-7445.AM2024-CT023","article-title":"Abstract CT023: Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Making a cold tumor hot","volume":"84","author":"Nair","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106646","article-title":"In Situ vaccination followed by IM poly-ICLC injections for the treatment of hepatocellular carcinoma in mouse models","volume":"188","author":"Weng","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.medj.2025.100879_bib34","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1038\/s41467-024-48073-y","article-title":"TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial","volume":"15","author":"Everson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100879_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00262-016-1834-5","article-title":"Designing therapeutic cancer vaccines by mimicking viral infections","volume":"66","author":"Sultan","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.medj.2025.100879_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00262-018-02294-5","article-title":"The route of administration dictates the immunogenicity of peptide-based camcer vaccines in mice","volume":"68","author":"Sultan","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.medj.2025.100879_bib37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00262-018-2164-6","article-title":"Role of MDA5 and interferon-1 in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice","volume":"67","author":"Sultan","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.medj.2025.100879_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00262-010-0876-3","article-title":"Poly-ICLC promotes the infltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-a and IFN-g dependent manners","volume":"59","author":"Zhu","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.medj.2025.100879_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001224","article-title":"Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration","volume":"8","author":"Sultan","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.20111171","article-title":"Synthetic double stranded RNA reliably induces innate immunity similar to a live viral vaccine in humans","volume":"208","author":"Caskey","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medj.2025.100879_bib41","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3390\/ijms22041626","article-title":"Hiltonol cocktail kills lung cancer cells by activating cancer suppressors PKR\/OAS and restraining the tumor microenvironment","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2025.100879_bib42","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/cncr.34790","article-title":"A novel prostate cancer subtyping classifier based on luminal and basal phenotypes","volume":"129","author":"Weiner","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s42003-021-02140-y","article-title":"Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences","volume":"4","author":"Rayford","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.medj.2025.100879_bib44","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1200\/JCO.2016.70.2811","article-title":"Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease","volume":"35","author":"Spratt","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.medj.2025.100879_bib45","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/cac2.12467","article-title":"Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race-specific luminal-basal and microenvironmental differences","volume":"43","author":"Chua","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.medj.2025.100879_bib46","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1158\/1078-0432.CCR-08-1982","article-title":"Prostate cancer-associated gene expression alterations determined from needle biopsies","volume":"15","author":"Qian","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.medj.2025.100879_bib48","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1172\/JCI20032","article-title":"Gene expression profiling predicts clinical outcome of prostate cancer","volume":"113","author":"Glinsky","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.medj.2025.100879_bib49","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100879_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2164-7-115","article-title":"Cell-type specific gene expression profiles of leukocytes in human peripheral blood","volume":"7","author":"Palmer","year":"2006","journal-title":"BMC Genom."},{"key":"10.1016\/j.medj.2025.100879_bib51","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.medj.2025.100879_bib52","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","article-title":"A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra","volume":"25","author":"Henry","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2025.100879_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2025.100879_bib54","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100879_bib55","article-title":"An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation","author":"Sergushichev","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.medj.2025.100879_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib57","article-title":"Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100879_bib58","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-020-00143-y","article-title":"Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets","volume":"1","author":"Bhardwaj","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib59","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.prp.2018.06.012","article-title":"Mesenchymal stem cells up-regulate the invasive potential of prostate cancer cells via the eotaxin-3\/CCR3 axis","volume":"214","author":"Ishida","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.medj.2025.100879_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41698-023-00407-7","article-title":"Targeting CDK1 in cancer: mechanisms and implications","volume":"7","author":"Wang","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.medj.2025.100879_bib61","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/s41598-021-81126-6","article-title":"CD117\/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance","volume":"11","author":"Harris","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2025.100879_bib62","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/0008-5472.CAN-14-0992","article-title":"CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy","volume":"75","author":"Escamilla","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib63","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41419-022-05289-4","article-title":"S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer","volume":"13","author":"Firdaus","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.medj.2025.100879_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073490","article-title":"The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2025.100879_bib65","first-page":"419","article-title":"Clinical significance of CXCL16\/CXCR6 expression in patients with prostate cancer","volume":"4","author":"Ha","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.medj.2025.100879_bib66","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.18632\/oncotarget.6944","article-title":"CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and alphavbeta3 integrin clustering","volume":"7","author":"Singh","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.medj.2025.100879_bib67","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1349-7006.2008.00833.x","article-title":"CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells","volume":"99","author":"Hu","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.medj.2025.100879_bib68","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/1541-7786.MCR-07-0277","article-title":"CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro","volume":"6","author":"Lu","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12859-018-2069-6","article-title":"A gene profiling deconvolution approach to estimating immune cell composition from complex tissues","volume":"19","author":"Chen","year":"2018","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.medj.2025.100879_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/JHC.S136652","article-title":"A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and system polyinosini-polycytidylic acid polylysine carboxymethilcellulose to treat liver cancer: in searh of the abscopal effect","volume":"4","author":"de la Torre","year":"2017","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.medj.2025.100879_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.800630","article-title":"Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor","volume":"12","author":"Song","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100879_bib72","article-title":"Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100879_bib73","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00262-019-02394-w","article-title":"Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy","volume":"68","author":"Zahm","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.medj.2025.100879_bib74","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.juro.2006.04.048","article-title":"Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading","volume":"176","author":"Donohue","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.medj.2025.100879_bib75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.medj.2025.100879_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euros.2023.08.001","article-title":"Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer","volume":"55","author":"Hougen","year":"2023","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.medj.2025.100879_bib77","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.eururo.2024.04.026","article-title":"The Role of Microsatellite Instability\/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer","volume":"86","author":"Klumper","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.medj.2025.100879_bib78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.eururo.2016.08.037","article-title":"DNA Repair in Prostate Cancer: Biology and Clinical Implications","volume":"71","author":"Mateo","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.medj.2025.100879_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1231536","article-title":"Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer","volume":"14","author":"Bugoye","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.medj.2025.100879_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674565","article-title":"Tertiary Lymphoid Structures as a prdictive biomarker of response to cancer inmmunotherapies","volume":"12","author":"Trub","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100879_bib81","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccell.2023.02.017","article-title":"B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity","volume":"41","author":"Laumont","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.medj.2025.100879_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.medj.2025.100879_bib83","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2017.00563","article-title":"A unique cellular and molecular microenvironment is present in TLS of patients with spontaneous prostat cancer regressio","volume":"8","author":"Garcia Hernandez","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.medj.2025.100879_bib84","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41590-023-01543-9","article-title":"Neoantigen specific stem cell memory like CD4 T cells mediat CD8 T cell dependent immunotherapy of MHC class II negative solid tumors","volume":"24","author":"Brightman","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.medj.2025.100879_bib85","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/nar\/gkw855","article-title":"Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-kappaB cistrome to reprogram the prostate cancer cell transcriptome","volume":"45","author":"Malinen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2025.100879_bib86","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/2767-9764.CRC-21-0139","article-title":"Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer","volume":"2","author":"Alizadeh-Ghodsi","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.medj.2025.100879_bib87","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.molimm.2003.11.022","article-title":"Specificity and degeneracy of T Cells","volume":"40","author":"Wilson","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.medj.2025.100879_bib88","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1158\/1078-0432.CCR-13-2781","article-title":"Combinatorial Immunotherapy of Poly-IC and blockade of PD-L1 induce effective CD8 T-cell responses against established tumors","volume":"20","author":"Nagato","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.medj.2025.100879_bib89","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00262-019-02418-5","article-title":"Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response","volume":"68","author":"Domankevich","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.medj.2025.100879_bib90","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/PAT.0b013e32834ba487","article-title":"Tertiary Gleason pattern 5 on needle biopsy predicts greater tumour volume on radical prostatectomy","volume":"43","author":"Ranaweera","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.medj.2025.100879_bib91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eururo.2020.10.033","article-title":"A Comparison of Genitourinary Society Pathology and International Society of Urological Pathology Prostate Cancer Guidelines","volume":"79","author":"Epstein","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.medj.2025.100879_bib92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejca.2021.09.016","article-title":"Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era","volume":"158","author":"Araujo","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.medj.2025.100879_bib93","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djp079","article-title":"Dose escalation methods in phase I cancer clinical trials","volume":"101","author":"Le Tourneau","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.medj.2025.100879_bib94","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/10543406.2017.1289952","article-title":"Dose-finding designs for trials of molecularly targeted agents and immunotherapies","volume":"27","author":"Chiuzan","year":"2017","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.medj.2025.100879_bib95","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2307\/2531693","article-title":"Design and analysis of phase I clinical trials","volume":"45","author":"Storer","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.medj.2025.100879_bib96","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/pcan.2016.38","article-title":"Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients","volume":"19","author":"Den","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.medj.2025.100879_bib97","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/bib\/bbq086","article-title":"Exon array data analysis using Affymetrix power tools and R statistical software","volume":"12","author":"Lockstone","year":"2011","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.medj.2025.100879_bib98","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygeno.2012.08.003","article-title":"A single-sample microarray normalization method to facilitate personalized-medicine workflows","volume":"100","author":"Piccolo","year":"2012","journal-title":"Genomics"},{"key":"10.1016\/j.medj.2025.100879_bib99","article-title":"Web-based analysis and publication of flow cytometry experiments","volume":"10","author":"Kotecha","year":"2010","journal-title":"Curr. Protoc. Cytom."},{"key":"10.1016\/j.medj.2025.100879_bib100","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.medj.2025.100879_bib101","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa163","article-title":"An approach for normalization and quality control for NanoString RNA expression data","volume":"22","author":"Bhattacharya","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.medj.2025.100879_bib102","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1158\/2159-8290.CD-23-0017","article-title":"Single cell view of tumor microenvironment gradients in pleural mesothelioma","volume":"14","author":"Giotti","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.medj.2025.100879_bib103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/2767-9764.CRC-22-0420","article-title":"A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma","volume":"3","author":"Chiu","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.medj.2025.100879_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.medj.2025.100879_bib105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663402500306X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663402500306X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:22:17Z","timestamp":1773278537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663402500306X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":105,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S266663402500306X"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100879","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Modulating the cold tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100879"}}